IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

This study has been completed.

Sponsor:

Information provided by:

Insys Therapeutics Inc

ClinicalTrials.gov Identifier:

NCT00089427

First received: August 5, 2004

Last updated: June 30, 2011

Last verified: April 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	July 2007 (Final data collection date for primary outcome measure)